By Times Chronicle Staff
A clinical research study by the Uterine Health Research Lab at the University of British Columbia (UBC) is seeking post-menopausal women to participate in a clinical study titled RESToRE.
This study is investigating screening tools for the early detection of endometrial cancer in postmenopausal women who do not have any symptoms.
Endometrial cancer is the most common gynecologic cancer in the developed world, with over 7,200 new cases diagnosed in Canada in 2023. In British Columbia, projections show a 50 per cent surge and a doubled mortality rate in the next decade, according to the RESToRE researchers.
Specifically, the researchers are aiming to recruit:
- Postmenopausal women;
- With an intact uterus (no hysterectomy);
- Who are not on any hormonal therapy, and;
- Are not experiencing abnormal bleeding (including spotting).
Lead Researchers (left to right): Dr. Aline Talhouk, Dr. Jessica McAlpine, Dr. Andrea Neilson.
Participation in the study is completely virtual and the researchers are hoping to enrol a diverse cohort across BC to inform future studies and standard care practices.
The study starts with a short 15-minute questionnaire that assesses potential risk factors for developing uterine cancer. After completing the questionnaire, those eligible to participate in the second phase will receive additional screenings to gather more information about their risk.
Individuals may be eligible to participate in a third phase of the study which offers a four-week personalized nutrition and exercise program specifically designed to help lower the risk of uterine cancer.
For more information visit the Uterine Health Research Lab website or email [email protected].
